Use Options For a Chance To Buy RARE at a 31% Discount
March 05, 2015 at 11:51 AM EST
Looking back to 29 days ago, Ultragenyx Pharmaceutical Inc (RARE) priced a 3,000,000 share secondary stock offering at $54.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Thursday, the stock is now 7% above the offering price..